Manuscripts
Showing 1590 manuscripts.
HIV-1 reservoir size after neonatal antiretroviral therapy and the potential to evaluate antiretroviral-therapy-free remission (IMPAACT P1115): a phase 1/2 proof-of-concept study
Citation
Deborah Persaud, Yvonne Bryson, Bryan S Nelson, Camlin Tierney, Mark F Cotton, Anne Coletti, Jennifer Jao, Stephen A Spector, Mark Mirochnick, Edmund V Capparelli, Diane Costello, Joseph Szewczyk, Nicol Nicodimus, Lynda Stranix-Chibanda, Adeodata R Kekitiinwa, Violet Korutaro, Christina Reding, Mary N Carrington, Sai Majji, Dwight E Yin, Patrick Jean-Philippe, Ellen G Chadwick. HIV-1 reservoir size after neonatal antiretroviral therapy and the potential to evaluate antiretroviral-therapy-free remission (IMPAACT P1115): a phase 1/2 proof-of-concept study. Lancet HIV. 2024 Jan 01; 23(00236-9):2352-3018. PMID: 38061376.Year
2024
Journal
Lancet HIV
Study
P1115
Weight changes and adverse pregnancy outcomes with dolutegravir- and tenofovir alafenamide fumarate-containing antiretroviral treatment regimens during pregnancy and postpartum
Citation
Risa M. Hoffman, Sean Brummel, Lauren Ziemba, Lameck Chinula, Jeffrey S A Stringer, Frances Nakayiwa, Avy Violari, Lee Fairlie, Victoria Ndyanabangi, Teacler G. Nematadzira, Sherika Hanley, Esau João, Linda Aurpibul, Mario Dias Correa Junior, Oranich Navanukroh, Neetal Nevrekar, Gerhard Theron, Cristina Barroso Hofer, Rebecca Zash, Roger Shapiro, Nahida Chakhtoura, Ben Johnston, Chelsea Krotje, Katie McCarthy, Patrick Jean-Philippe, Paul Sax, Judith S. Currier, Shahin Lockman, VESTED Study Team. Weight changes and adverse pregnancy outcomes with dolutegravir- and tenofovir alafenamide fumarate-containing antiretroviral treatment regimens during pregnancy and postpartum. Clinical Infectious Diseases. 2024 Jun 14; 78(6):1617-1628. PMID: 38180851; PMCID: PMC11175665.Year
2024
Journal
Clinical Infectious Diseases
Study
IMPAACT 2010
Impact of Genetic Variants in ABCG2, NR1I2 and UGT1A1 on the Pharmacokinetics of Dolutegravir in Children
Citation
Stephen A. Spector, Sean S. Brummel, Audrey Chang, Andrew Wiznia, Theodore D. Ruel, Edward P. Acosta, IMPAACT 1093 Team. Impact of Genetic Variants in ABCG2, NR1I2 and UGT1A1 on the Pharmacokinetics of Dolutegravir in Children. Journal of Acquired Immune Deficiency Syndromes. 2024 Mar 01; 95(3):doi: 10.1097/QAI.000000000000335. PMID: 38180896.Year
2024
Journal
Journal of Acquired Immune Deficiency Syndromes
Study
P1093
Bridging Dolutegravir Clinical Viral Response Across Doses and Formulations Using Model-Based Exposure-Response Analysis in Pediatrics
Citation
Hardik Chandasana, Rajendra Singh, Annie Buchanan, Cynthia Brothers, Andy Wiznia, Mattie Bartlett, Stephanie Popson, Ellen Townley, Rohan Hazra, Kathy George, Cindy Vavro, Theodore Ruel, Edward Acosta, IMPAACT P1093 Team. Bridging Dolutegravir Clinical Viral Response Across Doses and Formulations Using Model-Based Exposure-Response Analysis in Pediatrics. Journal of Acquired Immune Deficiency Syndromes. 2024 Jul 15; 8(9):F11-F18. PMID: 38768443.Year
2024
Journal
Journal of Acquired Immune Deficiency Syndromes
Study
P1093
Prevalence of detectable HIV-DNA and HIV-RNA in cerebrospinal fluid of youth with perinatal HIV and impaired cognition on antiretroviral therapy
Citation
Thor A. Wagner, Camlin Tierney, Sharon Huang, Sharon Nichols, Kathleen M. Malee, Nicole A. Montañez, Anne Coletti, Hans ML Spiegel, Chelsea Krotje, Frederic Bone, Megan Wilkins, Lisa Abuogi, Murli Purswani, Allison Bearden, Andrew Wiznia, Allison Agwu, Ellen G. Chadwick, Douglas Richman, Monica Gandhi, Patrick Mehta, Bernard Macatangay, Stephen A. Spector, Serena Spudich, Deborah Persaud, Ann Chahroudi, IMPAACT 2015 Protocol Team. Prevalence of detectable HIV-DNA and HIV-RNA in cerebrospinal fluid of youth with perinatal HIV and impaired cognition on antiretroviral therapy. AIDS. 2024 May 29; 38(10):1494-1504. PMID: 38814693.Year
2024
Journal
AIDS
Study
IMPAACT 2015
Pharmacokinetics and Safety of Remdesivir in Pregnant and Non-Pregnant Women with COVID: Results from IMPAACT 2032
Citation
Kristina M. Brooks, Kristin Baltrusaitis, Diana F. Clarke, Sharon Nachman, Jennifer Jao, Murli Purswani, Allison Agwu, Christy Beneri, Jaime G. Deville, Kathleen Powis, Alice M. Stek, Ahizechukwu Eke, David E. Shapiro, Edmund Capparelli, Elizabeth Greene, Kathleen George, Dwight E. Yin, Patrick Jean-Philippe, Nahida Chakhtoura, Frederic Bone, Kira Bacon, Benjamin Johnston, Christina Reding, Kathryn Kersey, Rita Humeniuk, Brookie M. Best, Mark Mirochnick, Jeremiah D. Momper, IMPAACT 2032 Study Team. Pharmacokinetics and Safety of Remdesivir in Pregnant and Non-Pregnant Women with COVID: Results from IMPAACT 2032. Journal of Infectious Diseases. 2024 Oct 16; 230(4):878-888. PMID: 38839047; PMCID: PMC11481345.Year
2024
Journal
Journal of Infectious Diseases
Study
IMPAACT 2032
Population Pharmacokinetic Modeling of Abacavir/Dolutegravir/Lamivudine to Support a Fixed-Dose Combination in Children with HIV-1
Citation
Hardik Chandasana, Sven C. van Dijkman, Rashmi Mehta, Mark Bush, Helena Rabie, Patricia Flynn, Tim R. Cressey, Edward P. Acosta, Kristina M. Brooks, IMPAACT 2019 Study Team. Population Pharmacokinetic Modeling of Abacavir/Dolutegravir/Lamivudine to Support a Fixed-Dose Combination in Children with HIV-1. Infectious Diseases and Therapy. 2024 Jul 04; PMID: 38961048; PMCID: PMC11266315.Year
2024
Journal
Infectious Diseases and Therapy
Study
IMPAACT 2019
Impact of in-utero exposure to HIV and latent TB on infant humoral responses
Citation
Kimberly J.S. Hjelmar, Lesley R. de Armas, Evan Goldberg, Suresh Pallikkuth, Jyoti Mathad, Grace Montepiedra, Amita Gupta, Savita Pahwa. Impact of in-utero exposure to HIV and latent TB on infant humoral responses. Frontiers in Immunology. 2024 Jun 26; 15:1423435. PMID: 38994354; PMCID: PMC11236605.Year
2024
Journal
Frontiers in Immunology
Study
P1078
Characterising HIV drug resistance in cases of vertical transmission in the VESTED randomized antiretroviral treatment trial
Citation
Violet Korutaro, Marley D. Bishop, Ceejay L. Boyce, Ingrid A. Beck, Sheila M. Styrchak, Kevin Knowles, Lauren Ziemba, Sean Bremmel, Anne Coletti, Patrick Jean Philippe, Nahida Chakhtoura, Tichaona Vhembo, Haseena Cassim, Maxensia Owor, Lee Fairlie, Sikhulile Moyo, Lameck Chinula, Shahin Lockman, Lisa M. Frenkel, IMPAACT 2010 Team. Characterising HIV drug resistance in cases of vertical transmission in the VESTED randomized antiretroviral treatment trial. Journal of International AIDS Society. 2024 Aug 01; 96(4):385-392. PMID: 39175843; PMCID: PMC11338623.Year
2024
Journal
Journal of International AIDS Society
Study
IMPAACT 2010
Dolutegravir- Versus Efavirenz-Based Treatment in Pregnancy: Impact on Red Blood Cell Folate Concentrations in Pregnant Women and Their Infants
Citation
Denise L. Jacobson, Krista S. Crider, Patricia DeMarrais, Sean Brummel, Mindy Zhang, Christine M. Pfeiffer, Cynthia A. Moore, Katie McCarthy, Benjamin Johnston, Terence Mohammed, Tichaona Vhembo, Enid Kabugho, Gerald Agaba Muzorah, Haseena Cassim, Lee Fairlie, Elizabeth S. Machado, James S. Ngocho, Roger L. Shapiro, Lena Serghides, Nahida Chakhtoura, Lameck Chinula, Shahin Lockman. Dolutegravir- Versus Efavirenz-Based Treatment in Pregnancy: Impact on Red Blood Cell Folate Concentrations in Pregnant Women and Their Infants. Journal of Infectious Diseases. 2024 Nov 15; 230(5):1224-1234. PMID: 38877762; PMCID: PMC11565887.Year
2024
Journal
Journal of Infectious Diseases
Study
IMPAACT 2010